Using IFN-γ as a marker of antitumour immune activation, we found that the number of IFN-γ-producing CD8+NKG2D+ cells was stimulated by HCC cells and was further significantly increased by MV-infected HCC cells (Fig. 2a). The gene discussed is IFNG; the disease is hepatocellular carcinoma.